We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

World’s First COVID-19 Drug Based on Human Immunoglobulin Developed from Plasma of Recovered Patients

By HospiMedica International staff writers
Posted on 14 Sep 2021

Illustration

The world’s first drug based on human immunoglobulin being developed from plasma of recovered patients could be effective on COVID-19 patients with mild conditions.

China National Pharmaceutical Group Co., Ltd. (Sinopharm Beijing, China) is developing two medicines for the treatment of COVID-19 based on human immunoglobulin and monoclonal antibody. Both the drugs could reduce the impact of the novel coronavirus in infected people and will be effective on patients with mild COVID-19, according to a report by the Global Times.

The first drug being developed from plasma of recovered COVID-19 patients or vaccinated uninfected people contains high-potency SARS-COV-2 neutralizing antibodies. The drug has demonstrated significant relief of symptoms and damage caused by SARS-COV-2 in pre-clinical studies and animal tests. The new drug containing a high level of neutralizing antibodies to the novel coronavirus is all set to soon enter Phase 3 clinical trials.

The second COVID-19 drug under development is based on a potent monoclonal antibody against the Delta variant discovered by researchers at Sinopharm. The monoclonal antibody is capable of effectively blocking the binding of the novel coronavirus to the Angiotensin-converting enzyme 2 which is attached to the membranes of cells located in the intestines, kidney, testes, gallbladder and heart. According to Sinopharm, the antibody can prevent the SARS-COV-2 virus from infecting human cells.

Related Links:
China National Pharmaceutical Group Co., Ltd.

Visit expo >

Gold Member

Handheld Blood Glucose Analyzer

STAT-Site

Gold Member

SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test

SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)

New

Desk Aneroid Sphyg

Diagnostix 750D+

New

Blood Pressure Monitor

Cuff Blood Pressure Monitor

Latest COVID-19 News

Channels

Artificial Intelligence

view channel

Image: Johns Hopkins computer scientist Suchi Saria began translating her lab’s research into a real-world system after losing her nephew to sepsis in 2017 (Photo courtesy of Will Kirk/Johns Hopkins University)

FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality

Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read more

Facial Image Analysis Tracks Biological Aging, Predicts Cancer Outcomes

Biological aging is the progressive loss of physiological function that may diverge from chronological age. In cancer care, clinicians need simple tools that reflect dynamic changes in patient resilience... Read more

AI Model Uses Eye Imaging to Identify Risk of Major Systemic Diseases

Early detection of systemic disease risk remains a persistent challenge in population health screening. Cardiometabolic conditions such as diabetes, heart disease, and stroke often progress without symptoms... Read more

AI Platform Interprets Real-Time Wearable Data for Parkinson’s Management

Parkinson’s disease presents fluctuating motor and non-motor symptoms that complicate day-to-day self-management and clinical decision-making. Care teams require timely, longitudinal insight into medication... Read more

Critical Care

view channel

Image: Summary of ECG2Stroke (Rahul Mahajan et al. JACC (2026). DOI: 10.1016/j.jacc.2026.03.084)

AI Model Predicts 10-Year Stroke Risk from Standard ECG

Stroke remains a major cause of death and long-term disability worldwide. Clinicians need scalable tools to identify people who face sustained risk years before an event occurs. Existing clinical scores... Read more

Implantable Cytokine Device Enables Localized Immunotherapy for Ovarian Cancer

High-grade serous ovarian carcinoma, the most lethal form of ovarian cancer, often disseminates throughout the peritoneal cavity and resists standard therapies. Systemic interleukin-2 (IL-2) can activate... Read more

AI Tool Predicts Risk of Out-of-Hospital Cardiac Arrest

Sudden cardiac arrest is a lethal event that often occurs without warning, causing more than 400,000 deaths in the U.S. each year and a survival rate of about 10%. Clinicians struggle to identify who in... Read more

Wearable Defibrillator Supports Quicker Beta-Blocker Optimization in Women

Women with newly diagnosed heart failure with reduced ejection fraction (HFrEF) often do not reach optimal beta-blocker dosing during early treatment. Guideline-directed titration depends on achieving... Read more

Surgical Techniques

view channel

Image: Even though the team’s new bioelectronic is only about the size of a fingertip, it could offer an effective and biocompatible approach to addressing high blood pressure (photo courtesy of Tao Zhou/Penn State)

Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study

Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more

FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment

The Evala Nerve Stimulator from Epineuron (Mississauga, ON, Canada) is a handheld, intraoperative electrical stimulation system designed to provide surgeons with a rapid and accurate method for nerve identification... Read more

Image: PrecisionView is a handheld endomicroscope that overcomes limitations in medical imaging by combining advanced optics with deep learning (photo courtesy of Rice University)

Handheld AI Endomicroscope Enables Real-Time Precancer Detection at Point of Care

Many epithelial cancers are detected late because current diagnostics rely on invasive biopsies and in vivo microscopy with narrow field and shallow depth of field. These constraints can make it difficult... Read more

Image: Shockwave C2 Aero, a next generation coronary intravascular lithotripsy (IVL) catheter that resets physicians’ expectations by addressing unmet needs in deliverability, lesion crossing and balloon repositioning (Photo courtesy of Johnson & Johnson)

Intravascular Lithotripsy Catheter Advances Treatment of Calcified Coronary Disease

Calcified coronary artery disease complicates revascularization by impeding device deliverability and lesion crossing, particularly in tortuous vessels. Coronary artery disease is the leading cause of... Read more

Patient Care

view channel

Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation

Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more

Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Image: A screengrab from the VR training module that shows invisible contamination on portable medical equipment (Photo courtesy of Mass General Brigham)

VR Training Tool Combats Contamination of Portable Medical Equipment

Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more

Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel

EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission

Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more

Image: The Viz Subdural solution is powered by the Viz.ai platform and includes Viz Assist, which provides artificial intelligence–driven chart summarization (photo courtesy of Viz.ai)

AI System Detects and Quantifies Chronic Subdural Hematoma

Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more

Image: AION’s TempShield is a U.S. FDA-cleared wearable that continuously monitors body temperature, capturing subtle changes that can signal early clinical deterioration (photo courtesy of AION Biosystems)

Continuous Monitoring Platform Detects Infection Risk Across Care Transitions

Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more

Point of Care

view channel

Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management

HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read more

Image: Hyperfine’s Swoop platform is a portable, ultra-low-field MRI system that is FDA-cleard for brain imaging in patients of all ages (photo courtesy of Hyperfine)

Portable MRI System Gains CE Mark for Point-of-Care Brain Imaging

Rapid neurological assessment in emergency and critical care often hinges on timely brain imaging, yet access to MRI at the point of care remains limited. Diffusion-weighted imaging is central to stroke... Read more

Image: The Nevisense uses a non-invasive procedure that combines EIS technology with AI to provide in-depth skin analysis (photo courtesy of SciBase)

AI-Enabled Platform Supports Clinical Decision-Making in Melanoma Detection

Visual examination remains the foundation of dermatologic assessment for suspicious skin lesions, and many dermatologists are confident using clinical and dermoscopic techniques. However, studies show... Read more

Business

view channel

Image: Under the agreement, robot-assisted technologies developed by EndoRobotics will be distributed worldwide as part of the Olympus EndoTherapy portfolio (Photo courtesy of EndoRobotics Co., Ltd)

Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy

Olympus has signed an exclusive global distribution agreement with EndoRobotics Co., Ltd., under which robot-assisted technologies developed by EndoRobotics will be distributed worldwide as part of the... Read more

Johnson & Johnson Launches AI-Driven Cardiac Mapping System

Johnson & Johnson has introduced the CARTOSOUND SONATA Module for the CARTO System at the Heart Rhythm Society (HRS) 2026 meeting in Chicago. The module uses artificial intelligence with the CARTO... Read more

Proximie Advances AI-Driven Intelligent Operating Rooms with NVIDIA Collaboration

Proximie has aligned with NVIDIA to advance intelligent operating rooms through Project Rheo, a new initiative to accelerate healthcare robotics and clinical environments. Proximie is building on NVIDIA... Read more

Image: Breast Suite is a cloud-based suite of modular, interoperable applications that integrates into existing breast imaging workflows (photo courtesy of DeepHealth)

GE HealthCare, DeepHealth Expand AI Breast Imaging Collaboration

GE HealthCare and DeepHealth, a RadNet subsidiary, have expanded their collaboration to bring enhanced capabilities of DeepHealth’s new AI-powered Breast Suite to market, including ProFound Pro and Safeguard Review.... Read more